Breast Cancer - News, Obesity Reviews, Recent Papers, and Clinical Trials

Dehesh T, Fadaghi S, Seyedi M, Abolhadi E, Ilaghi M, Shams P, Ajam F, Mosleh-Shirazi MA, Dehesh P. The relation between obesity and breast cancer risk in women by considering menstruation status and geographical variations: a systematic review and meta-analysis. BMC Womens Health. 2023 Jul 26;23(1):392. doi: 10.1186/s12905-023-02543-5. PMID: 37496015; PMCID: PMC10373406.

Summary
This research paper explores the relationship between obesity and breast cancer risk in women, taking into account both pre- and post-menopausal status as well as geographical variations. Using a meta-analysis of over 100 studies, researchers discovered that obesity appears to have a protective effect against breast cancer in pre-menopausal women, particularly in European women, while in post-menopausal women, obesity increases the risk of developing breast cancer across various continents. The researchers also identified factors that contributed to the heterogeneity observed across the studies, such as study design, geographical location, and hormonal drug use.

AI Generated Summary Podcast (10:31)

Current 27 Clinical Trials in Obesity and Breast Cancer at 41 sites in the United States (Recruiting or Not Yet Recruting)

NCT NumberStudy TitleStudy StatusConditionsSponsor
NCT06517212Tirzepatide in Patients With Obesity or Overweight Who Have High Risk Early Breast Cancer and Are ctDNA+NOT_YET_RECRUITINGBreast Cancer|Breast NeoplasmsBaylor Research Institute
NCT04720209Taking AIM at Breast CancerRECRUITINGBreast Cancer|Breast Cancer Stage I|Breast Cancer Stage II|Breast Cancer Stage IIIDana-Farber Cancer Institute
NCT04913064Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast CancerRECRUITINGBreast CarcinomaCity of Hope Medical Center
NCT06318507The Intestinal Microbiome in Triple Negative Breast Cancer Treated With ImmunotherapyRECRUITINGBreast NeoplasmsPennington Biomedical Research Center
NCT04003038Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction SurgeryRECRUITINGBody Mass Index Greater Than or Equal to 30|Malignant Breast Neoplasm|Mammoplasty Patient|ObesityM.D. Anderson Cancer Center
NCT063992764:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or ObesityRECRUITINGBreast CancerUniversity of Colorado, Denver
NCT05193149Inspiratory Muscle Training in Obese Breast Cancer SurvivorsRECRUITINGCancer Survivors|Obesity|Breast CancerOhio State University Comprehensive Cancer Center
NCT02095184GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese PatientsRECRUITINGBreast CancerUniversity of Maryland, Baltimore
NCT06485089Effects of Tirzepatide on Blood, Imaging and Breast Tissue BiomarkersRECRUITINGObesity|Breast Cancer RiskUniversity of Kansas Medical Center
NCT03824145Every Day Counts: A Lifestyle Program for Women With Metastatic Breast CancerRECRUITINGMetastatic Breast CancerMedical College of Wisconsin
NCT06518837Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast CancerNOT_YET_RECRUITINGHormone Receptor-Positive Breast Cancer|HER2-Negative Breast CancerRutgers, The State University of New Jersey
NCT06106477Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast CancerRECRUITINGBreast CancerMedical College of Wisconsin
NCT03712813Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer SurvivorsRECRUITINGBreast CancerIndiana University
NCT04365569Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling ProgramRECRUITINGBreast CancerCase Comprehensive Cancer Center
NCT04717050Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical ActivityRECRUITINGBreast Cancer|Coronary Artery Disease|Stroke|Type2 DiabetesDana-Farber Cancer Institute
NCT06195306Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk ReductionNOT_YET_RECRUITINGBreast Atypical Hyperplasia|Breast Carcinoma|Breast Ductal Carcinoma In Situ|Breast Lobular Carcinoma In SituNational Cancer Institute (NCI)
NCT05386719Cardiometabolic Screening ProgramRECRUITINGBreast Cancer|Early-stage Breast CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT05780814The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast CancerRECRUITINGBreast Cancer|Insomnia|Weight GainJohns Hopkins University
NCT05930483Remotely Delivered, Culturally Tailored Weight Loss Interventions Among Latina Breast Cancer SurvivorsNOT_YET_RECRUITINGAnatomic Stage I Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8Fred Hutchinson Cancer Center
NCT06504914Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer SurvivorsRECRUITINGHypertension|Obesity|Nutrition, HealthyUniversity of Illinois at Chicago
NCT05721976With Love, Grandma ("Con Cariño, Abuelita") Pilot StudyRECRUITINGCancer, Breast|Cancer, Uterus|Cancer, Ovary|Obesity|Activity, Motor|Diet, HealthyUniversity of Miami Sylvester Comprehensive Cancer Center
NCT06315296An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung CancerRECRUITINGAnatomic Stage IV Breast Cancer AJCC v8|Metastatic Breast Carcinoma|Metastatic Lung Carcinoma|Metastatic Malignant Neoplasm in the Brain|Stage IV Lung Cancer AJCC v8Thomas Jefferson University
NCT04965246Trial Assessing Light Intensity Exercise on the Health of Older Breast Cancer SurvivorsRECRUITINGInflammation|Cognitive Impairment|Anxiety|Alcohol DrinkingMilton S. Hershey Medical Center
NCT05848856The RISC Registry--Risk Informed Screening RegistryNOT_YET_RECRUITINGBreast Cancer Risk|Cardiovascular Disease Risk|Cardiometabolic Risk|DiabetesPrecision Health Equity Initiative
NCT06123286Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal SymptomsNOT_YET_RECRUITINGBreast Cancer|Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)|Joint PainPhilip Chang
NCT06171945Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsRECRUITINGCancer|Physical Activity|Cancer Survivorship|Mental Health|ObesityUNC Lineberger Comprehensive Cancer Center
NCT01793168Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRECRUITINGRare Disorders|Undiagnosed Disorders|Disorders of Unknown Prevalence|Cornelia De Lange Syndrome|Prenatal Benign Hypophosphatasia|Perinatal Lethal Hypophosphatasia|Odontohypophosphatasia|Adult Hypophosphatasia|Childhood-onset Hypophosphatasia|Infantile Hypophosphatasia|Hypophosphatasia|Kabuki Syndrome|Bohring-Opitz Syndrome|Narcolepsy Without Cataplexy|Narcolepsy-cataplexy|Hypersomnolence Disorder|Idiopathic Hypersomnia Without Long Sleep Time|Idiopathic Hypersomnia With Long Sleep Time|Idiopathic Hypersomnia|Kleine-Levin Syndrome|Kawasaki Disease|Leiomyosarcoma|Leiomyosarcoma of the Corpus Uteri|Leiomyosarcoma of the Cervix Uteri|Leiomyosarcoma of Small Intestine|Acquired Myasthenia Gravis|Addison Disease|Hyperacusis (Hyperacousis)|Juvenile Myasthenia Gravis|Transient Neonatal Myasthenia Gravis|Williams Syndrome|Lyme Disease|Myasthenia Gravis|Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome)|Isolated Klippel-Feil Syndrome|Frasier Syndrome|Denys-Drash Syndrome|Beckwith-Wiedemann Syndrome|Emanuel Syndrome|Isolated Aniridia|Axenfeld-Rieger Syndrome|Aniridia-intellectual Disability Syndrome|Aniridia - Renal Agenesis - Psychomotor Retardation|Aniridia - Ptosis - Intellectual Disability - Familial Obesity|Aniridia - Cerebellar Ataxia - Intellectual Disability|Aniridia - Absent Patella|Aniridia|Peters Anomaly - Cataract|Peters Anomaly|Potocki-Shaffer Syndrome|Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11|Silver-Russell Syndrome Due to Imprinting Defect of 11p15|Silver-Russell Syndrome Due to 11p15 Microduplication|Syndromic Aniridia|WAGR Syndrome|Wolf-Hirschhorn Syndrome|4p16.3 Microduplication Syndrome|4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome|Autosomal Recessive Stickler Syndrome|Stickler Syndrome Type 2|Stickler Syndrome Type 1|Stickler Syndrome|Mucolipidosis Type 4|X-linked Spinocerebellar Ataxia Type 4|X-linked Spinocerebellar Ataxia Type 3|X-linked Intellectual Disability - Ataxia - Apraxia|X-linked Progressive Cerebellar Ataxia|X-linked Non Progressive Cerebellar Ataxia|X-linked Cerebellar Ataxia|Vitamin B12 Deficiency Ataxia|Toxic Exposure Ataxia|Unclassified Autosomal Dominant Spinocerebellar Ataxia|Thyroid Antibody Ataxia|Sporadic Adult-onset Ataxia of Unknown Etiology|Spinocerebellar Ataxia With Oculomotor Anomaly|Spinocerebellar Ataxia With Epilepsy|Spinocerebellar Ataxia With Axonal Neuropathy Type 2|Spinocerebellar Ataxia Type 8|Spinocerebellar Ataxia Type 7|Spinocerebellar Ataxia Type 6|Spinocerebellar Ataxia Type 5|Spinocerebellar Ataxia Type 4|Spinocerebellar Ataxia Type 37|Spinocerebellar Ataxia Type 36|Spinocerebellar Ataxia Type 35|Spinocerebellar Ataxia Type 34|Spinocerebellar Ataxia Type 32|Spinocerebellar Ataxia Type 31|Spinocerebellar Ataxia Type 30|Spinocerebellar Ataxia Type 3|Spinocerebellar Ataxia Type 29|Spinocerebellar Ataxia Type 28|Spinocerebellar Ataxia Type 27|Spinocerebellar Ataxia Type 26|Spinocerebellar Ataxia Type 25|Spinocerebellar Ataxia Type 23|Spinocerebellar Ataxia Type 22|Spinocerebellar Ataxia Type 21|Spinocerebellar Ataxia Type 20|Spinocerebellar Ataxia Type 2|Spinocerebellar Ataxia Type 19/22|Spinocerebellar Ataxia Type 18|Spinocerebellar Ataxia Type 17|Spinocerebellar Ataxia Type 16|Spinocerebellar Ataxia Type 15/16|Spinocerebellar Ataxia Type 14|Spinocerebellar Ataxia Type 13|Spinocerebellar Ataxia Type 12|Spinocerebellar Ataxia Type 11|Spinocerebellar Ataxia Type 10|Spinocerebellar Ataxia Type 1 With Axonal Neuropathy|Spinocerebellar Ataxia Type 1|Spinocerebellar Ataxia - Unknown|Spinocerebellar Ataxia - Dysmorphism|Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature|Spasticity-ataxia-gait Anomalies Syndrome|Spastic Ataxia With Congenital Miosis|Spastic Ataxia - Corneal Dystrophy|Spastic Ataxia|Rare Hereditary Ataxia|Rare Ataxia|Recessive Mitochondrial Ataxia Syndrome|Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature|Posterior Column Ataxia - Retinitis Pigmentosa|Post-Stroke Ataxia|Post-Head Injury Ataxia|Post Vaccination Ataxia|Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract|Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus|Non-hereditary Degenerative Ataxia|Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity|Olivopontocerebellar Atrophy - Deafness|NARP Syndrome|Myoclonus - Cerebellar Ataxia - Deafness|Multiple System Atrophy, Parkinsonian Type|Multiple System Atrophy, Cerebellar Type|Multiple System Atrophy|Maternally-inherited Leigh Syndrome|Machado-Joseph Disease Type 3|Machado-Joseph Disease Type 2|Machado-Joseph Disease Type 1|Leigh Syndrome|Late-onset Ataxia With Dementia|Infection or Post Infection Ataxia|GAD Ataxia|Hereditary Episodic Ataxia|Gliadin/Gluten Ataxia|Friedreich Ataxia|Fragile X-associated Tremor/Ataxia Syndrome|Familial Paroxysmal Ataxia|Exposure to Medications Ataxia|Episodic Ataxia With Slurred Speech|Episodic Ataxia Unknown Type|Episodic Ataxia Type 7|Episodic Ataxia Type 6|Episodic Ataxia Type 5|Episodic Ataxia Type 4|Episodic Ataxia Type 3|Episodic Ataxia Type 1|Epilepsy and/or Ataxia With Myoclonus as Major Feature|Early-onset Spastic Ataxia-neuropathy Syndrome|Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity|Early-onset Cerebellar Ataxia With Retained Tendon Reflexes|Early-onset Ataxia With Dementia|Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia|Dilated Cardiomyopathy With Ataxia|Cataract - Ataxia - Deafness|Cerebellar Ataxia, Cayman Type|Cerebellar Ataxia With Peripheral Neuropathy|Cerebellar Ataxia - Hypogonadism|Cerebellar Ataxia - Ectodermal Dysplasia|Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss|Brain Tumor Ataxia|Brachydactyly - Nystagmus - Cerebellar Ataxia|Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia|Autosomal Recessive Syndromic Cerebellar Ataxia|Autosomal Recessive Spastic Ataxia With Leukoencephalopathy|Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay|Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria|Autosomal Recessive Spastic Ataxia|Autosomal Recessive Metabolic Cerebellar Ataxia|Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine|Autosomal Recessive Ataxia, Beauce Type|Autosomal Recessive Ataxia Due to Ubiquinone Deficiency|Autosomal Recessive Ataxia Due to PEX10 Deficiency|Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia|Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency|Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency|Autosomal Recessive Congenital Cerebellar Ataxia|Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome|Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity|Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency|Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect|Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion|Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation|Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness|Autosomal Recessive Cerebellar Ataxia|Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly|Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation|Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy|Autosomal Dominant Spastic Ataxia Type 1|Autosomal Dominant Spastic Ataxia|Autosomal Dominant Optic Atrophy|Ataxia-telangiectasia Variant|Ataxia-telangiectasia|Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy|Autosomal Dominant Cerebellar Ataxia Type 4|Autosomal Dominant Cerebellar Ataxia Type 3|Autosomal Dominant Cerebellar Ataxia Type 2|Autosomal Dominant Cerebellar Ataxia Type 1|Autosomal Dominant Cerebellar Ataxia|Ataxia-telangiectasia-like Disorder|Ataxia With Vitamin E Deficiency|Ataxia With Dementia|Ataxia - Oculomotor Apraxia Type 1|Ataxia - Other|Ataxia - Genetic Diagnosis - Unknown|Acquired Ataxia|Adult-onset Autosomal Recessive Cerebellar Ataxia|Alcohol Related Ataxia|Multiple Endocrine Neoplasia|Multiple Endocrine Neoplasia Type II|Multiple Endocrine Neoplasia Type 1|Multiple Endocrine Neoplasia Type 2|Multiple Endocrine Neoplasia, Type IV|Multiple Endocrine Neoplasia, Type 3|Multiple Endocrine Neoplasia (MEN) Syndrome|Multiple Endocrine Neoplasia Type 2B|Multiple Endocrine Neoplasia Type 2A|Atypical Hemolytic Uremic Syndrome|Atypical HUS|Wiedemann-Steiner Syndrome|Breast Implant-Associated Anaplastic Large Cell Lymphoma|Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA)|Hemophagocytic Lymphohistiocytosis|Behcet's Disease|Alagille Syndrome|Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD)|Lowe Syndrome|Pitt Hopkins Syndrome|1p36 Deletion Syndrome|Jansen Type Metaphyseal Chondrodysplasia|Cockayne Syndrome|Chronic Recurrent Multifocal Osteomyelitis|CRMO|Malan Syndrome|Hereditary Sensory and Autonomic Neuropathy Type Ie|VCP Disease|Hypnic Jerking|Sleep Myoclonus|Mollaret Meningitis|Recurrent Viral Meningitis|CRB1|Leber Congenital Amaurosis|Retinitis Pigmentosa|Rare Retinal Disorder|KCNMA1-Channelopathy|Primary Biliary Cirrhosis|ZMYND11|Transient Global Amnesia|Glycogen Storage Disease|Alstrom Syndrome|White Sutton Syndrome|DNM1|EIEE31|Myhre Syndrome|Recurrent Respiratory Papillomatosis|Laryngeal Papillomatosis|Tracheal Papillomatosis|Refsum Disease|Nicolaides Baraitser Syndrome|Leukodystrophy|Tango2|Cauda Equina Syndrome|Rare Gastrointestinal Disorders|Achalasia-Addisonian Syndrome|Achalasia Cardia|Achalasia Icrocephaly Syndrome|Anal Fistula|Congenital Sucrase-Isomaltase Deficiency|Eosinophilic Gastroenteritis|Idiopathic Gastroparesis|Hirschsprung Disease|Rare Inflammatory Bowel Disease|Intestinal Pseudo-Obstruction|Scleroderma|Short Bowel Syndrome|Sacral Agenesis|Sacral Agenesis Syndrome|Caudal Regression|Scheuermann Disease|SMC1A Truncated Mutations (Causing Loss of Gene Function)|Cystinosis|Juvenile Nephropathic Cystinosis|Nephropathic Cystinosis|Kennedy Disease|Spinal Bulbar Muscular Atrophy|Warburg Micro Syndrome|Mucolipidoses|Mitochondrial Diseases|Mitochondrial Aminoacyl-tRNA Synthetases|Mt-aaRS Disorders|Hypertrophic Olivary Degeneration|Non-Ketotic Hyperglycinemia|Fish Odor Syndrome|Halitosis|Isolated Congenital Asplenia|Lambert Eaton (LEMS)|Biliary Atresia|STAG1 Gene Mutation|Coffin Lowry Syndrome|Borjeson-Forssman-Lehman Syndrome|Blau Syndrome|Arginase 1 Deficiency|HSPB8 Myopathy|Beta-Mannosidosis|TBX4 Syndrome|DHDDS Gene Mutations|MAND-MBD5-Associated Neurodevelopmental Disorder|Constitutional Mismatch Repair Deficiency (CMMRD)|SPATA5 Disorder|SPATA5L1 Related DisorderSanford Health

Clinical Trials

Breast Cancer Clinical Trials in the United States that involve obesity – Total of 130 (October 7, 2024)

https://clinicaltrials.gov/search?locStr=United%20States&country=United%20States&cond=Breast%20Cancer&term=Obesity

NCT NumberStudy TitleStudy URLAcronymStudy StatusConditions
NCT01302379Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT01302379COMPLETEDBreast Neoplasms
NCT00933309The Impact of Obesity and Obesity Treatments on Breast Cancerhttps://clinicaltrials.gov/study/NCT00933309COMPLETEDBreast Cancer
NCT06517212Tirzepatide in Patients With Obesity or Overweight Who Have High Risk Early Breast Cancer and Are ctDNA+https://clinicaltrials.gov/study/NCT06517212NOT_YET_RECRUITINGBreast Cancer|Breast Neoplasms
NCT04720209Taking AIM at Breast Cancerhttps://clinicaltrials.gov/study/NCT04720209RECRUITINGBreast Cancer|Breast Cancer Stage I|Breast Cancer Stage II|Breast Cancer Stage III
NCT04913064Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancerhttps://clinicaltrials.gov/study/NCT04913064RECRUITINGBreast Carcinoma
NCT02750826Breast Cancer WEight Loss Study (BWEL Study)https://clinicaltrials.gov/study/NCT02750826ACTIVE_NOT_RECRUITINGBreast Carcinoma
NCT03091842Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancerhttps://clinicaltrials.gov/study/NCT03091842WITHDRAWNCancer Survivor|Central Obesity|Estrogen Receptor Positive|Postmenopausal|Progesterone Receptor Positive|Stage I Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage III Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
NCT04003038Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgeryhttps://clinicaltrials.gov/study/NCT04003038RECRUITINGBody Mass Index Greater Than or Equal to 30|Malignant Breast Neoplasm|Mammoplasty Patient|Obesity
NCT063992764:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesityhttps://clinicaltrials.gov/study/NCT06399276RECRUITINGBreast Cancer
NCT02681120Pilot Study of the Effect of Weight Loss on Breast Tissue and Blood Biomarkers in Women at Increased Risk for Breast Cancerhttps://clinicaltrials.gov/study/NCT02681120COMPLETEDBreast Neoplasms|Obesity
NCT03111680Healthy Families to Change Obesity in Public Housing Residentshttps://clinicaltrials.gov/study/NCT03111680COMPLETEDBreast Cancer
NCT02028221Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Riskhttps://clinicaltrials.gov/study/NCT02028221COMPLETEDBreast Cancer Prevention
NCT01472445Vitamin D and Breast Cancer: Does Weight Make a Difference?https://clinicaltrials.gov/study/NCT01472445TERMINATEDBreast Cancer
NCT02538484Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjectshttps://clinicaltrials.gov/study/NCT02538484COMPLETEDBreast Cancer
NCT04504201Patient-centered Communication About Healthy Weight in Early Breast Cancerhttps://clinicaltrials.gov/study/NCT04504201COMPLETEDBreast Cancer
NCT01975363Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancerhttps://clinicaltrials.gov/study/NCT01975363COMPLETEDAtypical Ductal Breast Hyperplasia|BRCA1 Gene Mutation|BRCA2 Gene Mutation|Ductal Breast Carcinoma in Situ|Lobular Breast Carcinoma in Situ
NCT03575624Changing Health Behaviors to Manage Chronic Conditions in Community-dwelling African American Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT03575624COMPLETEDBreast Cancer Female|Survivorship
NCT01127867A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Womenhttps://clinicaltrials.gov/study/NCT01127867COMPLETEDBreast Cancer|Obesity
NCT02095184GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patientshttps://clinicaltrials.gov/study/NCT02095184RECRUITINGBreast Cancer
NCT02062255Impact of COX2 on Sera Biomarkers From Obese Subjectshttps://clinicaltrials.gov/study/NCT02062255COMPLETEDBreast Cancer Survivors
NCT00859989A Weight-Loss Program in Helping Obese Black Women Lose Weighthttps://clinicaltrials.gov/study/NCT00859989UNKNOWNBreast Cancer|Obesity|Weight Changes
NCT04117438Tell us Your Food Storyhttps://clinicaltrials.gov/study/NCT04117438WITHDRAWNBreast Neoplasms
NCT01542203Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancerhttps://clinicaltrials.gov/study/NCT01542203WITHDRAWNBreast Cancer
NCT05113485UCLA Breast Cancer Survivor Health Promotion Research Studyhttps://clinicaltrials.gov/study/NCT05113485UNKNOWNBreast Cancer
NCT02432950Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancerhttps://clinicaltrials.gov/study/NCT02432950COMPLETEDObesity|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
NCT01582685Exercise in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT01582685WITHDRAWNBreast Cancer|Obesity
NCT06485089Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkershttps://clinicaltrials.gov/study/NCT06485089NOT_YET_RECRUITINGObesity|Breast Cancer Risk
NCT01784042Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissuehttps://clinicaltrials.gov/study/NCT01784042WITHDRAWNBreast Cancer
NCT03029182Simulated-altitude to Optimize Aerobic Exercise Among Breast Cancer Survivors With Limited Mobilityhttps://clinicaltrials.gov/study/NCT03029182COMPLETEDObesity|Breast Cancer
NCT01793948Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancerhttps://clinicaltrials.gov/study/NCT01793948COMPLETEDBreast Cancer|Obesity
NCT01837147Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study)https://clinicaltrials.gov/study/NCT01837147COMPLETEDBreast Cancer
NCT01441011Rural Women Connecting for Better Healthhttps://clinicaltrials.gov/study/NCT01441011COMPLETEDBreast Cancer|Obesity
NCT04291950Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Womenhttps://clinicaltrials.gov/study/NCT04291950WITHDRAWNTriple Negative Breast Cancer
NCT04298086A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancerhttps://clinicaltrials.gov/study/NCT04298086ACTIVE_NOT_RECRUITINGBreast Cancer|Primary Hormone Receptor Positive Breast Cancer
NCT01504789Part II: Exercise in Hispanic Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT01504789ACTIVE_NOT_RECRUITINGBreast Cancer
NCT00343434Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weighthttps://clinicaltrials.gov/study/NCT00343434COMPLETEDBreast Cancer|Obesity
NCT01537029Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamidehttps://clinicaltrials.gov/study/NCT01537029COMPLETEDBreast Cancer|Obesity
NCT00131950Effect of Lifestyle Factors and Hormone Function on Breast Density in Healthy Hispanic Women Who Are Undergoing Mammography for Breast Cancer Screeninghttps://clinicaltrials.gov/study/NCT00131950COMPLETEDBreast Cancer
NCT00120029Peer Counseling for Weight Losshttps://clinicaltrials.gov/study/NCT00120029UNKNOWNBreast Cancer
NCT01166672BCRL Prevention Pilothttps://clinicaltrials.gov/study/NCT01166672COMPLETEDObesity|Breast Cancer
NCT01627067Exemestane-RAD001-Metforminhttps://clinicaltrials.gov/study/NCT01627067TERMINATEDBreast Cancer
NCT02574507Behavioral Weight and Symptom Management for Breast Cancer Survivors and Partnershttps://clinicaltrials.gov/study/NCT02574507COMPLETEDBreast Cancer
NCT06106477Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancerhttps://clinicaltrials.gov/study/NCT06106477RECRUITINGBreast Cancer
NCT03712813Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT03712813RECRUITINGBreast Cancer
NCT05265715A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT05265715COMPLETEDBreast Cancer
NCT02969291A Home-Based Study to Enhance Activity in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT02969291COMPLETEDBreast Cancer
NCT02279303Rx for Better Breast Healthhttps://clinicaltrials.gov/study/NCT02279303COMPLETEDBreast Cancer
NCT04129346Technology-Supported Physical Activity Intervention for Metastatic Breast Cancer Survivors: Fit2ThriveMBhttps://clinicaltrials.gov/study/NCT04129346COMPLETEDMetastatic Breast Cancer|Obesity
NCT04365569Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Programhttps://clinicaltrials.gov/study/NCT04365569RECRUITINGBreast Cancer
NCT04170335Effects of Bariatric Surgery on Breast Density Improvement and Impact on Breast Cancer Risk in Severe Obese Patientshttps://clinicaltrials.gov/study/NCT04170335WITHDRAWNBreast Cancer|Morbid Obesity|Bariatric Surgery Candidate
NCT03270111High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Womenhttps://clinicaltrials.gov/study/NCT03270111COMPLETEDBreast Cancer Female
NCT02940470Weight Loss Pilot Study in Postmenopausal Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT02940470COMPLETEDBreast Cancer|Obesity|Overweight
NCT04717050Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activityhttps://clinicaltrials.gov/study/NCT04717050RECRUITINGBreast Cancer|Coronary Artery Disease|Stroke|Type2 Diabetes
NCT00904033Calcitriol, Physical Activity, and Bone Health in Cancer Survivorshttps://clinicaltrials.gov/study/NCT00904033COMPLETEDBreast Neoplasms|Bone and Bones
NCT04330339Prolonged Nightly Fasting in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT04330339COMPLETEDFasting|Breast Cancer|Survivorship|Breast Cancer Recurrent
NCT00470119Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal Womenhttps://clinicaltrials.gov/study/NCT00470119COMPLETEDBreast Cancer|Obesity|Weight Changes
NCT06195306Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reductionhttps://clinicaltrials.gov/study/NCT06195306NOT_YET_RECRUITINGBreast Atypical Hyperplasia|Breast Carcinoma|Breast Ductal Carcinoma In Situ|Breast Lobular Carcinoma In Situ
NCT05386719Cardiometabolic Screening Programhttps://clinicaltrials.gov/study/NCT05386719RECRUITINGBreast Cancer|Early-stage Breast Cancer
NCT04321135Avanzando Juntas: Adapting an Evidence Based Weight Loss Program for Hispanic Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT04321135COMPLETEDBreast Cancer|Gynecologic Cancer
NCT04967209Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancerhttps://clinicaltrials.gov/study/NCT04967209COMPLETEDCancer|Breast Cancer|Obesity|Overweight and Obesity|Overweight
NCT04554316Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgeryhttps://clinicaltrials.gov/study/NCT04554316COMPLETEDScar|Breast Neoplasms|Breast Diseases|Surgical Wound
NCT00872677Weight Loss Counseling for African American Women Who Are Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT00872677COMPLETEDBreast Cancer|Obesity|Weight Changes
NCT02938780Using Behavioral Economics to Achieve Improved Healthy Behavior Outcomes in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT02938780COMPLETEDBreast Cancer Female
NCT02677857Developing a Healthy Lifestyle in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT02677857TERMINATEDBreast Cancer|Sedentary Lifestyle
NCT03120390Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT03120390WITHDRAWNCancer Survivor|Central Obesity|No Evidence of Disease
NCT04741802TOPS for African American Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT04741802COMPLETEDFeasibility and Acceptability of the TOPS Program|Obesity|Breast Cancer|Weight Loss
NCT04210128Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatmenthttps://clinicaltrials.gov/study/NCT04210128COMPLETEDBreast Cancer|Pancreatic Cancer|Diabetes|Pre Diabetes
NCT02871388Addressing Modifiable Breast Cancer Risk Factors With Project CONECThttps://clinicaltrials.gov/study/NCT02871388COMPLETEDWeight Loss|Breast Cancer Risk Factors
NCT01157130Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratoryhttps://clinicaltrials.gov/study/NCT01157130UNKNOWNEarly Stage Breast Cancer (Stage 0-III)
NCT02370277Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancerhttps://clinicaltrials.gov/study/NCT02370277COMPLETEDDuctal Breast Carcinoma In Situ|Invasive Breast Carcinoma|Stage I Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer
NCT04454086Exercise and Diet Counseling Program in Improving Quality of Life in Stage I-III Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT04454086COMPLETEDAnatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Cancer Survivor|Obesity|Overweight|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8
NCT01871116POWER-remote Weight Loss Program in Early Stage Breast Cancerhttps://clinicaltrials.gov/study/NCT01871116COMPLETEDEarly Stage Breast Cancer
NCT05930483Remotely Delivered, Culturally Tailored Weight Loss Interventions Among Latina Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT05930483NOT_YET_RECRUITINGAnatomic Stage I Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8
NCT02037542A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancerhttps://clinicaltrials.gov/study/NCT02037542COMPLETEDWeight
NCT03546972Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participantshttps://clinicaltrials.gov/study/NCT03546972ACTIVE_NOT_RECRUITINGDeleterious BRCA1 Gene Mutation|Deleterious BRCA2 Gene Mutation|Ductal Breast Carcinoma In Situ|Obesity|Overweight|Premalignant Lesion
NCT02923401High-Intensity Interval Training for Women at Heightened Risk for Breast Cancerhttps://clinicaltrials.gov/study/NCT02923401COMPLETEDDisorders of Breast
NCT00509626Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapyhttps://clinicaltrials.gov/study/NCT00509626COMPLETEDBreast Cancer|Depression|Fatigue|Psychosocial Effects of Cancer and Its Treatment|Weight Changes
NCT05012176An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT05012176ACTIVE_NOT_RECRUITINGAnatomic Stage 0 Breast Cancer AJCC v8|Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Breast Ductal Carcinoma In Situ|Invasive Breast Carcinoma|Prognostic Stage 0 Breast Cancer AJCC v8|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8
NCT04799665Dedicated Breast CT for Quantitative Breast Density Measurements in Mexican-origin Women in Southern Arizonahttps://clinicaltrials.gov/study/NCT04799665COMPLETEDMetabolic Syndrome|Obesity Associated Disorder
NCT02103140An Exercise RCT Targeting African-American Women With Metabolic Syndrome and High Risk for Breast Cancerhttps://clinicaltrials.gov/study/NCT02103140ACTIVE_NOT_RECRUITINGMetabolic Syndrome|Obesity
NCT04753268Mobile Behavior Change Program for Weight Loss in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT04753268COMPLETEDWeight Loss|Behavior, Health
NCT03284346Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivorshttps://clinicaltrials.gov/study/NCT03284346TERMINATEDCancer Survivor|No Evidence of Disease|Obesity|Overweight|Prostate Carcinoma|Sedentary Lifestyle|Stage I Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage III Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
NCT05721976With Love, Grandma ("Con Cariño, Abuelita") Pilot Studyhttps://clinicaltrials.gov/study/NCT05721976RECRUITINGCancer, Breast|Cancer, Uterus|Cancer, Ovary|Obesity|Activity, Motor|Diet, Healthy
NCT06315296An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancerhttps://clinicaltrials.gov/study/NCT06315296RECRUITINGAnatomic Stage IV Breast Cancer AJCC v8|Metastatic Breast Carcinoma|Metastatic Lung Carcinoma|Metastatic Malignant Neoplasm in the Brain|Stage IV Lung Cancer AJCC v8
NCT04352530Culturally Appropriate Nutrition Communication for Mexican American Womenhttps://clinicaltrials.gov/study/NCT04352530COMPLETEDLifestyle Risk Reduction|Nutrition Poor|Chronic Disease|Obesity|Cancer, Breast
NCT03751449Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT03751449TERMINATEDAnatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Cancer Survivor|Inactivity|Obesity|Overweight|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8
NCT06123286Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptomshttps://clinicaltrials.gov/study/NCT06123286NOT_YET_RECRUITINGBreast Cancer|Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)|Joint Pain
NCT00032201Cell Lines From High-Risk Breast Tissuehttps://clinicaltrials.gov/study/NCT00032201COMPLETEDHealthy
NCT04063410Evaluation of Perforator Phase Contrast Angiography in Developing Surgery Plans for Patients With Breast Cancer Undergoing Breast Reconstruction With Free-Flap Methods After Mastectomyhttps://clinicaltrials.gov/study/NCT04063410WITHDRAWNMammoplasty Patient
NCT04499950Adaptive Nutrition and Exercise Weight Loss (A-NEW) Studyhttps://clinicaltrials.gov/study/NCT04499950A-NEWACTIVE_NOT_RECRUITINGBreast Cancer|Overweight or Obesity
NCT03779867Acute Exercise Intervention in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT03779867ACEACTIVE_NOT_RECRUITINGBreast Carcinoma
NCT04534309Behavioral Weight Loss Program for Cancer Survivors in Marylandhttps://clinicaltrials.gov/study/NCT04534309ASPIRECOMPLETEDBreast Cancer|Prostate Cancer|Melanoma (Skin)|Endometrial Cancer|Gallbladder Cancer|Rectal Cancer|Kidney Cancer|Bladder Cancer
NCT06171945Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivorshttps://clinicaltrials.gov/study/NCT06171945AYAConnectRECRUITINGCancer|Physical Activity|Cancer Survivorship|Mental Health|Obesity
NCT04576247Combined Modality Exercise and Appetite in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT04576247CARETERMINATEDBreast Cancer Female|Overweight and Obesity
NCT01315483Diet Composition, Weight Control, and Breast Carcinogenesishttps://clinicaltrials.gov/study/NCT01315483CHOICECOMPLETEDBreast Cancer
NCT03542604Cancer, Obesity/Overweight and Insomnia Studyhttps://clinicaltrials.gov/study/NCT03542604COINCOMPLETEDBreast Cancer|Overweight and Obesity|Insomnia
NCT05780814The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancerhttps://clinicaltrials.gov/study/NCT05780814COINRECRUITINGBreast Cancer|Insomnia|Weight Gain
NCT01793168Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanfordhttps://clinicaltrials.gov/study/NCT01793168CoRDSRECRUITINGRare Disorders|Undiagnosed Disorders|Disorders of Unknown Prevalence|Cornelia De Lange Syndrome|Prenatal Benign Hypophosphatasia|Perinatal Lethal Hypophosphatasia|Odontohypophosphatasia|Adult Hypophosphatasia|Childhood-onset Hypophosphatasia|Infantile Hypophosphatasia|Hypophosphatasia|Kabuki Syndrome|Bohring-Opitz Syndrome|Narcolepsy Without Cataplexy|Narcolepsy-cataplexy|Hypersomnolence Disorder|Idiopathic Hypersomnia Without Long Sleep Time|Idiopathic Hypersomnia With Long Sleep Time|Idiopathic Hypersomnia|Kleine-Levin Syndrome|Kawasaki Disease|Leiomyosarcoma|Leiomyosarcoma of the Corpus Uteri|Leiomyosarcoma of the Cervix Uteri|Leiomyosarcoma of Small Intestine|Acquired Myasthenia Gravis|Addison Disease|Hyperacusis (Hyperacousis)|Juvenile Myasthenia Gravis|Transient Neonatal Myasthenia Gravis|Williams Syndrome|Lyme Disease|Myasthenia Gravis|Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome)|Isolated Klippel-Feil Syndrome|Frasier Syndrome|Denys-Drash Syndrome|Beckwith-Wiedemann Syndrome|Emanuel Syndrome|Isolated Aniridia|Axenfeld-Rieger Syndrome|Aniridia-intellectual Disability Syndrome|Aniridia - Renal Agenesis - Psychomotor Retardation|Aniridia - Ptosis - Intellectual Disability - Familial Obesity|Aniridia - Cerebellar Ataxia - Intellectual Disability|Aniridia - Absent Patella|Aniridia|Peters Anomaly - Cataract|Peters Anomaly|Potocki-Shaffer Syndrome|Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11|Silver-Russell Syndrome Due to Imprinting Defect of 11p15|Silver-Russell Syndrome Due to 11p15 Microduplication|Syndromic Aniridia|WAGR Syndrome|Wolf-Hirschhorn Syndrome|4p16.3 Microduplication Syndrome|4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome|Autosomal Recessive Stickler Syndrome|Stickler Syndrome Type 2|Stickler Syndrome Type 1|Stickler Syndrome|Mucolipidosis Type 4|X-linked Spinocerebellar Ataxia Type 4|X-linked Spinocerebellar Ataxia Type 3|X-linked Intellectual Disability - Ataxia - Apraxia|X-linked Progressive Cerebellar Ataxia|X-linked Non Progressive Cerebellar Ataxia|X-linked Cerebellar Ataxia|Vitamin B12 Deficiency Ataxia|Toxic Exposure Ataxia|Unclassified Autosomal Dominant Spinocerebellar Ataxia|Thyroid Antibody Ataxia|Sporadic Adult-onset Ataxia of Unknown Etiology|Spinocerebellar Ataxia With Oculomotor Anomaly|Spinocerebellar Ataxia With Epilepsy|Spinocerebellar Ataxia With Axonal Neuropathy Type 2|Spinocerebellar Ataxia Type 8|Spinocerebellar Ataxia Type 7|Spinocerebellar Ataxia Type 6|Spinocerebellar Ataxia Type 5|Spinocerebellar Ataxia Type 4|Spinocerebellar Ataxia Type 37|Spinocerebellar Ataxia Type 36|Spinocerebellar Ataxia Type 35|Spinocerebellar Ataxia Type 34|Spinocerebellar Ataxia Type 32|Spinocerebellar Ataxia Type 31|Spinocerebellar Ataxia Type 30|Spinocerebellar Ataxia Type 3|Spinocerebellar Ataxia Type 29|Spinocerebellar Ataxia Type 28|Spinocerebellar Ataxia Type 27|Spinocerebellar Ataxia Type 26|Spinocerebellar Ataxia Type 25|Spinocerebellar Ataxia Type 23|Spinocerebellar Ataxia Type 22|Spinocerebellar Ataxia Type 21|Spinocerebellar Ataxia Type 20|Spinocerebellar Ataxia Type 2|Spinocerebellar Ataxia Type 19/22|Spinocerebellar Ataxia Type 18|Spinocerebellar Ataxia Type 17|Spinocerebellar Ataxia Type 16|Spinocerebellar Ataxia Type 15/16|Spinocerebellar Ataxia Type 14|Spinocerebellar Ataxia Type 13|Spinocerebellar Ataxia Type 12|Spinocerebellar Ataxia Type 11|Spinocerebellar Ataxia Type 10|Spinocerebellar Ataxia Type 1 With Axonal Neuropathy|Spinocerebellar Ataxia Type 1|Spinocerebellar Ataxia - Unknown|Spinocerebellar Ataxia - Dysmorphism|Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature|Spasticity-ataxia-gait Anomalies Syndrome|Spastic Ataxia With Congenital Miosis|Spastic Ataxia - Corneal Dystrophy|Spastic Ataxia|Rare Hereditary Ataxia|Rare Ataxia|Recessive Mitochondrial Ataxia Syndrome|Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature|Posterior Column Ataxia - Retinitis Pigmentosa|Post-Stroke Ataxia|Post-Head Injury Ataxia|Post Vaccination Ataxia|Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract|Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus|Non-hereditary Degenerative Ataxia|Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity|Olivopontocerebellar Atrophy - Deafness|NARP Syndrome|Myoclonus - Cerebellar Ataxia - Deafness|Multiple System Atrophy, Parkinsonian Type|Multiple System Atrophy, Cerebellar Type|Multiple System Atrophy|Maternally-inherited Leigh Syndrome|Machado-Joseph Disease Type 3|Machado-Joseph Disease Type 2|Machado-Joseph Disease Type 1|Leigh Syndrome|Late-onset Ataxia With Dementia|Infection or Post Infection Ataxia|GAD Ataxia|Hereditary Episodic Ataxia|Gliadin/Gluten Ataxia|Friedreich Ataxia|Fragile X-associated Tremor/Ataxia Syndrome|Familial Paroxysmal Ataxia|Exposure to Medications Ataxia|Episodic Ataxia With Slurred Speech|Episodic Ataxia Unknown Type|Episodic Ataxia Type 7|Episodic Ataxia Type 6|Episodic Ataxia Type 5|Episodic Ataxia Type 4|Episodic Ataxia Type 3|Episodic Ataxia Type 1|Epilepsy and/or Ataxia With Myoclonus as Major Feature|Early-onset Spastic Ataxia-neuropathy Syndrome|Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity|Early-onset Cerebellar Ataxia With Retained Tendon Reflexes|Early-onset Ataxia With Dementia|Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia|Dilated Cardiomyopathy With Ataxia|Cataract - Ataxia - Deafness|Cerebellar Ataxia, Cayman Type|Cerebellar Ataxia With Peripheral Neuropathy|Cerebellar Ataxia - Hypogonadism|Cerebellar Ataxia - Ectodermal Dysplasia|Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss|Brain Tumor Ataxia|Brachydactyly - Nystagmus - Cerebellar Ataxia|Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia|Autosomal Recessive Syndromic Cerebellar Ataxia|Autosomal Recessive Spastic Ataxia With Leukoencephalopathy|Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay|Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria|Autosomal Recessive Spastic Ataxia|Autosomal Recessive Metabolic Cerebellar Ataxia|Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine|Autosomal Recessive Ataxia, Beauce Type|Autosomal Recessive Ataxia Due to Ubiquinone Deficiency|Autosomal Recessive Ataxia Due to PEX10 Deficiency|Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia|Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency|Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency|Autosomal Recessive Congenital Cerebellar Ataxia|Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency|Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome|Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity|Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency|Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect|Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion|Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation|Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness|Autosomal Recessive Cerebellar Ataxia|Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly|Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation|Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy|Autosomal Dominant Spastic Ataxia Type 1|Autosomal Dominant Spastic Ataxia|Autosomal Dominant Optic Atrophy|Ataxia-telangiectasia Variant|Ataxia-telangiectasia|Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy|Autosomal Dominant Cerebellar Ataxia Type 4|Autosomal Dominant Cerebellar Ataxia Type 3|Autosomal Dominant Cerebellar Ataxia Type 2|Autosomal Dominant Cerebellar Ataxia Type 1|Autosomal Dominant Cerebellar Ataxia|Ataxia-telangiectasia-like Disorder|Ataxia With Vitamin E Deficiency|Ataxia With Dementia|Ataxia - Oculomotor Apraxia Type 1|Ataxia - Other|Ataxia - Genetic Diagnosis - Unknown|Acquired Ataxia|Adult-onset Autosomal Recessive Cerebellar Ataxia|Alcohol Related Ataxia|Multiple Endocrine Neoplasia|Multiple Endocrine Neoplasia Type II|Multiple Endocrine Neoplasia Type 1|Multiple Endocrine Neoplasia Type 2|Multiple Endocrine Neoplasia, Type IV|Multiple Endocrine Neoplasia, Type 3|Multiple Endocrine Neoplasia (MEN) Syndrome|Multiple Endocrine Neoplasia Type 2B|Multiple Endocrine Neoplasia Type 2A|Atypical Hemolytic Uremic Syndrome|Atypical HUS|Wiedemann-Steiner Syndrome|Breast Implant-Associated Anaplastic Large Cell Lymphoma|Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA)|Hemophagocytic Lymphohistiocytosis|Behcet's Disease|Alagille Syndrome|Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD)|Lowe Syndrome|Pitt Hopkins Syndrome|1p36 Deletion Syndrome|Jansen Type Metaphyseal Chondrodysplasia|Cockayne Syndrome|Chronic Recurrent Multifocal Osteomyelitis|CRMO|Malan Syndrome|Hereditary Sensory and Autonomic Neuropathy Type Ie|VCP Disease|Hypnic Jerking|Sleep Myoclonus|Mollaret Meningitis|Recurrent Viral Meningitis|CRB1|Leber Congenital Amaurosis|Retinitis Pigmentosa|Rare Retinal Disorder|KCNMA1-Channelopathy|Primary Biliary Cirrhosis|ZMYND11|Transient Global Amnesia|Glycogen Storage Disease|Alstrom Syndrome|White Sutton Syndrome|DNM1|EIEE31|Myhre Syndrome|Recurrent Respiratory Papillomatosis|Laryngeal Papillomatosis|Tracheal Papillomatosis|Refsum Disease|Nicolaides Baraitser Syndrome|Leukodystrophy|Tango2|Cauda Equina Syndrome|Rare Gastrointestinal Disorders|Achalasia-Addisonian Syndrome|Achalasia Cardia|Achalasia Icrocephaly Syndrome|Anal Fistula|Congenital Sucrase-Isomaltase Deficiency|Eosinophilic Gastroenteritis|Idiopathic Gastroparesis|Hirschsprung Disease|Rare Inflammatory Bowel Disease|Intestinal Pseudo-Obstruction|Scleroderma|Short Bowel Syndrome|Sacral Agenesis|Sacral Agenesis Syndrome|Caudal Regression|Scheuermann Disease|SMC1A Truncated Mutations (Causing Loss of Gene Function)|Cystinosis|Juvenile Nephropathic Cystinosis|Nephropathic Cystinosis|Kennedy Disease|Spinal Bulbar Muscular Atrophy|Warburg Micro Syndrome|Mucolipidoses|Mitochondrial Diseases|Mitochondrial Aminoacyl-tRNA Synthetases|Mt-aaRS Disorders|Hypertrophic Olivary Degeneration|Non-Ketotic Hyperglycinemia|Fish Odor Syndrome|Halitosis|Isolated Congenital Asplenia|Lambert Eaton (LEMS)|Biliary Atresia|STAG1 Gene Mutation|Coffin Lowry Syndrome|Borjeson-Forssman-Lehman Syndrome|Blau Syndrome|Arginase 1 Deficiency|HSPB8 Myopathy|Beta-Mannosidosis|TBX4 Syndrome|DHDDS Gene Mutations|MAND-MBD5-Associated Neurodevelopmental Disorder|Constitutional Mismatch Repair Deficiency (CMMRD)|SPATA5 Disorder|SPATA5L1 Related Disorder
NCT01096901Choose to Lose for Women-Weight Loss to Reduce Breast Cancer Risk Factorshttps://clinicaltrials.gov/study/NCT01096901CTLCOMPLETEDObesity|Overweight
NCT02224807Effects of Diet and Exercise on Ductal Carcinoma in Situhttps://clinicaltrials.gov/study/NCT02224807DCISCOMPLETEDDuctal Carcinoma In Situ|Breast Cancer
NCT04300478Appetite and Exercise in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT04300478EARNEStCOMPLETEDOverweight|Breast Cancer|Obesity
NCT03824145Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancerhttps://clinicaltrials.gov/study/NCT03824145EDCRECRUITINGMetastatic Breast Cancer
NCT01112839Reducing Breast Cancer Recurrence With Weight Losshttps://clinicaltrials.gov/study/NCT01112839ENERGYCOMPLETEDBreast Cancer|Overweight|Obesity
NCT01498536Effect of Diet and Exercise in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT01498536F4F tri negCOMPLETEDBreast Cancer|Obesity
NCT06504914Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT06504914FIM-BCSRECRUITINGHypertension|Obesity|Nutrition, Healthy
NCT06518837Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancerhttps://clinicaltrials.gov/study/NCT06518837FITWISENOT_YET_RECRUITINGHormone Receptor-Positive Breast Cancer|HER2-Negative Breast Cancer
NCT05193149Inspiratory Muscle Training in Obese Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT05193149IMOCSRECRUITINGCancer Survivors|Obesity|Breast Cancer
NCT06318507The Intestinal Microbiome in Triple Negative Breast Cancer Treated With Immunotherapyhttps://clinicaltrials.gov/study/NCT06318507IMPACTRECRUITINGBreast Neoplasms
NCT01728506An Internet-based Weight Loss and Exercise Intervention for Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT01728506iWEBUNKNOWNBreast Cancer
NCT01559194Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Riskhttps://clinicaltrials.gov/study/NCT01559194LEAFCOMPLETEDBreast Cancer|Weight Loss
NCT02681965A Mail and Video-based Weight Loss Trial in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT02681965LEAN3COMPLETEDBreast Cancer Survivorship|Obesity
NCT02255240LEVEL UP: Video Games for Activity in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT02255240LEVEL UPWITHDRAWNBreast Cancer|Obesity
NCT01896050Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancerhttps://clinicaltrials.gov/study/NCT01896050LOGRIBMETCOMPLETEDBreast Cancer|Arthralgia|Obesity
NCT01630499My Lifestyle Intervention of Food and Exercisehttps://clinicaltrials.gov/study/NCT01630499MyLIFECOMPLETEDBreast Cancer
NCT02273206Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Womenhttps://clinicaltrials.gov/study/NCT02273206PCM3COMPLETEDDepression|Breast Cancer Screening|Cervical Cancer Screening|Colorectal Cancer Screening
NCT00782366Predictive Genetic Risk Assessment Trialhttps://clinicaltrials.gov/study/NCT00782366PGTCOMPLETEDColon Cancer|Lung Cancer|Atrial Fibrillation|Diabetes Type 2|Obesity|Breast Cancer|Graves Disease|Osteoarthritis|Celiac Disease|Myocardial Infarction|Prostate Cancer
NCT02152462Exergaming Intervention and Breast Cancer Biomarkers in Black Womenhttps://clinicaltrials.gov/study/NCT02152462POWERCOMPLETEDBreast Cancer|Obesity
NCT05048108Remote Assessment of Cognition, Insulin Resistance and Omega-3 Fatty Acid Biomarkers in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT05048108RACIRO-3ACTIVE_NOT_RECRUITINGBreast Cancer|Obesity
NCT05848856The RISC Registry--Risk Informed Screening Registryhttps://clinicaltrials.gov/study/NCT05848856RISCNOT_YET_RECRUITINGBreast Cancer Risk|Cardiovascular Disease Risk|Cardiometabolic Risk|Diabetes
NCT04326660SCOPE-Chinese Women Studyhttps://clinicaltrials.gov/study/NCT04326660SCOPECOMPLETEDCancer, Breast|Obesity, Abdominal
NCT00774371Weight Reduction Intervention for Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT00774371SHAPECOMPLETEDBreast Cancer
NCT02341235Self-monitoring Activity: a Randomized Trial of Game-oriented Applicationshttps://clinicaltrials.gov/study/NCT02341235SMARTGOALCOMPLETEDBreast Cancer|Obesity
NCT02431676Survivorship Promotion In Reducing IGF-1 Trialhttps://clinicaltrials.gov/study/NCT02431676SPIRITCOMPLETEDBreast Cancer|Prostate Cancer|Lung Cancer|Colon Cancer|Melanoma of Skin|Endometrial Cancer|Liver Cancer|Pancreatic Cancer|Rectal Cancer|Kidney Cancer|Other Solid Malignant Tumors
NCT04965246Trial Assessing Light Intensity Exercise on the Health of Older Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT04965246TALIEHORECRUITINGInflammation|Cognitive Impairment|Anxiety|Alcohol Drinking
NCT04855552Telehealth Weight Loss Program for Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT04855552TWLACTIVE_NOT_RECRUITINGCancer Survivors|Cancer of Breast|Body Weight|Overweight and Obesity
NCT01482702Impact of Weight Loss Interventions for Overweight Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT01482702VCC0910COMPLETEDOverweight|Postmenopausal|Breast Cancer
NCT01240213Vitamin D, Diet and Activity Studyhttps://clinicaltrials.gov/study/NCT01240213ViDACOMPLETEDBreast Cancer|Obesity|Hypovitaminosis D
NCT00393172Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)]https://clinicaltrials.gov/study/NCT00393172WISERCOMPLETEDBreast Cancer|Obesity
NCT01515124The Women In Steady Exercise Research (WISER) Survivor Trialhttps://clinicaltrials.gov/study/NCT01515124WISER SurvivorCOMPLETEDLymphedema
NCT00476203Yoga Study in Breast Cancer Patientshttps://clinicaltrials.gov/study/NCT00476203YogaCOMPLETEDBreast Cancer

New and existing studies added or modified at clinicaltrials.gov

https://clinicaltrials.gov/find-studies/rss

Recent Breast Cancer News

Load More

Breast Cancer Reviews

To see all 186 Reviews, go directly to PubMed.

RSS REVIEWS from PubMed – July 5, 2024 – Obesity AND Cancer AND Breast AND Review

Obesity Breast Cancer Papers

To see all >777 Papers, go directly to PubMed.

RSS RECENT PAPERS from PubMed – July 5, 2024 – Obesity (in title) AND Cancer (in title) AND Breast (in title)

US Clinical Trials involving Breast Cancer and Obesity

(update March 24, 2024)

NCT NumberStudy TitleStudy URLAcronymStudy StatusInterventionsSponsorCollaboratorsEnrollmentStudy Type
NCT01302379Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT01302379COMPLETEDDRUG: Metformin|DRUG: Placebo|BEHAVIORAL: Lifestyle intervention|BEHAVIORAL: Standard printed dietary guidelinesUniversity of California, San Diego333INTERVENTIONAL
NCT00933309The Impact of Obesity and Obesity Treatments on Breast Cancerhttps://clinicaltrials.gov/study/NCT00933309COMPLETEDDRUG: Exemestane|DRUG: AvandametM.D. Anderson Cancer CenterSusan G. Komen Breast Cancer Foundation25INTERVENTIONAL
NCT04720209Taking AIM at Breast Cancerhttps://clinicaltrials.gov/study/NCT04720209RECRUITINGOTHER: CARE|OTHER: TARE|OTHER: Home-Based StretchingDana-Farber Cancer InstituteNational Cancer Institute (NCI)300INTERVENTIONAL
NCT04913064Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancerhttps://clinicaltrials.gov/study/NCT04913064RECRUITINGOTHER: Questionnaire Administration|DRUG: White Button Mushroom ExtractCity of Hope Medical CenterNational Cancer Institute (NCI)26INTERVENTIONAL
NCT06318507The Intestinal Microbiome in Triple Negative Breast Cancer Treated With Immunotherapyhttps://clinicaltrials.gov/study/NCT06318507IMPACTRECRUITINGCOMBINATION_PRODUCT: Fecal microbial diversityPennington Biomedical Research Center25OBSERVATIONAL
NCT02750826Breast Cancer WEight Loss Study (BWEL Study)https://clinicaltrials.gov/study/NCT02750826ACTIVE_NOT_RECRUITINGOTHER: Health Education Program|OTHER: Weight Loss InterventionAlliance for Clinical Trials in OncologyNational Cancer Institute (NCI)|Division of Cancer Control|NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)|Canadian Cancer Trials Group3177INTERVENTIONAL
NCT03779867Acute Exercise Intervention in Breast Cancer Survivorshttps://clinicaltrials.gov/study/NCT03779867ACEACTIVE_NOT_RECRUITINGBEHAVIORAL: Exercise Intervention|OTHER: Resting|OTHER: Biomarker Analysis|OTHER: Questionnaire AdministrationFred Hutchinson Cancer CenterBreast Cancer Research Foundation105INTERVENTIONAL
NCT03091842Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancerhttps://clinicaltrials.gov/study/NCT03091842WITHDRAWNBEHAVIORAL: Exercise Intervention|BEHAVIORAL: Exercise Intervention|BEHAVIORAL: Exercise Intervention|OTHER: Informational Intervention|OTHER: Laboratory Biomarker Analysis|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire AdministrationUniversity of Southern CaliforniaNational Cancer Institute (NCI)0INTERVENTIONAL
NCT04003038Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgeryhttps://clinicaltrials.gov/study/NCT04003038RECRUITINGPROCEDURE: Negative Pressure Wound Therapy|PROCEDURE: Wound Care ManagementM.D. Anderson Cancer CenterNational Cancer Institute (NCI)80INTERVENTIONAL
NCT063992764:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesityhttps://clinicaltrials.gov/study/NCT06399276NOT_YET_RECRUITINGBEHAVIORAL: Weight LossUniversity of Colorado, DenverNational Cancer Institute (NCI)36INTERVENTIONAL

Clinical Trials in Breast Cancer that involve obesity